Nuevas herramientas para el tratamiento de la diabetes tipo 1 en la edad pediátrica

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Enrique Palomo Atance
Format: Artículo científico
Language:es
Published: Asociación Española de Pediatría de Atención Primaria 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876474953590636544
author Enrique Palomo Atance
author_facet Enrique Palomo Atance
contents Nuevas herramientas para el tratamiento de la diabetes tipo 1 en la edad pediátrica Enrique Palomo Atance Ana Belén Suárez Lascano Laura Acero García de la Santa Medicina tipo 1 Teplizumab Diabetes mellitus Monitorización continua de glucosa Sistemas híbridos avanzados de asa cerrada In recent years, new resources have been appearing in order to improve glycaemic control in patients with type 1 diabetes. These include new insulin analogues, glucose monitoring, smart insulin pens and hybrid close-loop systems. So, in these patients the percentage of time in range has increased, the episodes of hypoglycaemia or hyperglycaemia have decreased, and quality of life has improved. Finally, in the following years biological drugs such as teplizumab will be incorporated, which will be the first etiological treatment for type 1 diabetes. 2024 otro 1139-7632 https://www.redalyc.org/articulo.oa?id=366682341016 https://www.redalyc.org/journal/3666/366682341016/ https://www.redalyc.org/journal/3666/366682341016/html/ https://www.redalyc.org/journal/3666/366682341016/366682341016.epub https://www.redalyc.org/journal/3666/366682341016/movil 10.60147/40a65e5a es http://www.redalyc.org/revista.oa?id=3666 Pediatría Atención Primaria application/pdf Asociación Española de Pediatría de Atención Primaria Pediatría Atención Primaria (España) Num.103 Vol.XXVI
format Artículo científico
id redalyc_366682341016
institution Redalyc
language es
publishDate 2024
publisher Asociación Española de Pediatría de Atención Primaria
spellingShingle Nuevas herramientas para el tratamiento de la diabetes tipo 1 en la edad pediátrica
Enrique Palomo Atance
Medicina
tipo 1
Teplizumab
Diabetes mellitus
Monitorización continua de glucosa
Sistemas híbridos avanzados de asa cerrada
Nuevas herramientas para el tratamiento de la diabetes tipo 1 en la edad pediátrica Enrique Palomo Atance Ana Belén Suárez Lascano Laura Acero García de la Santa Medicina tipo 1 Teplizumab Diabetes mellitus Monitorización continua de glucosa Sistemas híbridos avanzados de asa cerrada In recent years, new resources have been appearing in order to improve glycaemic control in patients with type 1 diabetes. These include new insulin analogues, glucose monitoring, smart insulin pens and hybrid close-loop systems. So, in these patients the percentage of time in range has increased, the episodes of hypoglycaemia or hyperglycaemia have decreased, and quality of life has improved. Finally, in the following years biological drugs such as teplizumab will be incorporated, which will be the first etiological treatment for type 1 diabetes. 2024 otro 1139-7632 https://www.redalyc.org/articulo.oa?id=366682341016 https://www.redalyc.org/journal/3666/366682341016/ https://www.redalyc.org/journal/3666/366682341016/html/ https://www.redalyc.org/journal/3666/366682341016/366682341016.epub https://www.redalyc.org/journal/3666/366682341016/movil 10.60147/40a65e5a es http://www.redalyc.org/revista.oa?id=3666 Pediatría Atención Primaria application/pdf Asociación Española de Pediatría de Atención Primaria Pediatría Atención Primaria (España) Num.103 Vol.XXVI
title Nuevas herramientas para el tratamiento de la diabetes tipo 1 en la edad pediátrica
topic Medicina
tipo 1
Teplizumab
Diabetes mellitus
Monitorización continua de glucosa
Sistemas híbridos avanzados de asa cerrada
url https://www.redalyc.org/articulo.oa?id=366682341016
https://www.redalyc.org/journal/3666/366682341016/
https://www.redalyc.org/journal/3666/366682341016/html/
https://www.redalyc.org/journal/3666/366682341016/366682341016.epub
https://www.redalyc.org/journal/3666/366682341016/movil